OA11936A - Method for the preservation of viruses and mycoplasma. - Google Patents
Method for the preservation of viruses and mycoplasma. Download PDFInfo
- Publication number
- OA11936A OA11936A OA1200100290A OA1200100290A OA11936A OA 11936 A OA11936 A OA 11936A OA 1200100290 A OA1200100290 A OA 1200100290A OA 1200100290 A OA1200100290 A OA 1200100290A OA 11936 A OA11936 A OA 11936A
- Authority
- OA
- OAPI
- Prior art keywords
- virus
- matrix
- drying
- température
- trehalose
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title claims abstract description 63
- 238000000034 method Methods 0.000 title claims abstract description 60
- 241000204031 Mycoplasma Species 0.000 title claims abstract description 14
- 238000004321 preservation Methods 0.000 title description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims abstract description 31
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims abstract description 30
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims abstract description 30
- 229960005486 vaccine Drugs 0.000 claims abstract description 30
- 239000011159 matrix material Substances 0.000 claims abstract description 27
- 239000011149 active material Substances 0.000 claims abstract description 16
- 238000001035 drying Methods 0.000 claims description 66
- 239000000203 mixture Substances 0.000 claims description 20
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 241000711897 Rinderpest morbillivirus Species 0.000 claims description 6
- 241001428894 Small ruminant morbillivirus Species 0.000 claims description 5
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 239000007900 aqueous suspension Substances 0.000 claims description 4
- 239000011521 glass Substances 0.000 claims description 4
- 241000711404 Avian avulavirus 1 Species 0.000 claims description 3
- 241000283690 Bos taurus Species 0.000 claims description 3
- 241000991587 Enterovirus C Species 0.000 claims description 3
- 241000711386 Mumps virus Species 0.000 claims description 3
- 206010035664 Pneumonia Diseases 0.000 claims description 2
- 239000012736 aqueous medium Substances 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- SGPGESCZOCHFCL-UHFFFAOYSA-N Tilisolol hydrochloride Chemical compound [Cl-].C1=CC=C2C(=O)N(C)C=C(OCC(O)C[NH2+]C(C)(C)C)C2=C1 SGPGESCZOCHFCL-UHFFFAOYSA-N 0.000 claims 2
- 241000712079 Measles morbillivirus Species 0.000 claims 1
- 206010037660 Pyrexia Diseases 0.000 claims 1
- 241000710799 Rubella virus Species 0.000 claims 1
- 241000607479 Yersinia pestis Species 0.000 claims 1
- 208000037933 contagious bovine pleuropneumonia Diseases 0.000 claims 1
- 238000004108 freeze drying Methods 0.000 abstract description 15
- 239000000463 material Substances 0.000 abstract description 8
- 230000008569 process Effects 0.000 abstract description 5
- 238000001291 vacuum drying Methods 0.000 abstract description 2
- 239000000047 product Substances 0.000 description 34
- 229940074410 trehalose Drugs 0.000 description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- 239000000546 pharmaceutical excipient Substances 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 208000006257 Rinderpest Diseases 0.000 description 9
- 239000002609 medium Substances 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- 230000002238 attenuated effect Effects 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000011534 incubation Methods 0.000 description 5
- 238000002941 microtiter virus yield reduction assay Methods 0.000 description 5
- 238000002255 vaccination Methods 0.000 description 5
- DPVHGFAJLZWDOC-PVXXTIHASA-N (2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxane-3,4,5-triol;dihydrate Chemical compound O.O.O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 DPVHGFAJLZWDOC-PVXXTIHASA-N 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 229940074409 trehalose dihydrate Drugs 0.000 description 4
- 208000007634 Peste-des-Petits-Ruminants Diseases 0.000 description 3
- 244000309466 calf Species 0.000 description 3
- 230000000120 cytopathologic effect Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000007710 freezing Methods 0.000 description 3
- 230000008014 freezing Effects 0.000 description 3
- 210000003501 vero cell Anatomy 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 102000004407 Lactalbumin Human genes 0.000 description 2
- 108090000942 Lactalbumin Proteins 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 102100038126 Tenascin Human genes 0.000 description 2
- 108010008125 Tenascin Proteins 0.000 description 2
- 208000036142 Viral infection Diseases 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 239000004411 aluminium Substances 0.000 description 2
- 229940031567 attenuated vaccine Drugs 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 229920005549 butyl rubber Polymers 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000000254 damaging effect Effects 0.000 description 2
- 150000002016 disaccharides Chemical class 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 238000012809 post-inoculation Methods 0.000 description 2
- 230000000644 propagated effect Effects 0.000 description 2
- 201000005404 rubella Diseases 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000000859 sublimation Methods 0.000 description 2
- 230000008022 sublimation Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- DEXFNLNNUZKHNO-UHFFFAOYSA-N 6-[3-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-3-oxopropyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)C(CCC1=CC2=C(NC(O2)=O)C=C1)=O DEXFNLNNUZKHNO-UHFFFAOYSA-N 0.000 description 1
- 241000238582 Artemia Species 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 241000589567 Brucella abortus Species 0.000 description 1
- 229920003043 Cellulose fiber Polymers 0.000 description 1
- 241001647378 Chlamydia psittaci Species 0.000 description 1
- 241000224483 Coccidia Species 0.000 description 1
- 208000000655 Distemper Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 241000710831 Flavivirus Species 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 241000231614 Macrobiotus hufelandi Species 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 241000202936 Mycoplasma mycoides Species 0.000 description 1
- 102000011931 Nucleoproteins Human genes 0.000 description 1
- 108010061100 Nucleoproteins Proteins 0.000 description 1
- 208000002606 Paramyxoviridae Infections Diseases 0.000 description 1
- 241000711502 Paramyxovirinae Species 0.000 description 1
- 241000711798 Rabies lyssavirus Species 0.000 description 1
- 241000710801 Rubivirus Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000142921 Tardigrada Species 0.000 description 1
- 201000005485 Toxoplasmosis Diseases 0.000 description 1
- 208000003152 Yellow Fever Diseases 0.000 description 1
- 241000710772 Yellow fever virus Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 229940056450 brucella abortus Drugs 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 208000014058 canine distemper Diseases 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000005138 cryopreservation Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003631 expected effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000009477 glass transition Effects 0.000 description 1
- 125000005640 glucopyranosyl group Chemical group 0.000 description 1
- -1 glucose Chemical class 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000001524 infective effect Effects 0.000 description 1
- 210000003292 kidney cell Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940124590 live attenuated vaccine Drugs 0.000 description 1
- 229940023012 live-attenuated vaccine Drugs 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 230000008723 osmotic stress Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 201000006509 pleuropneumonia Diseases 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000004544 sputter deposition Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 125000000647 trehalose group Chemical group 0.000 description 1
- 210000000605 viral structure Anatomy 0.000 description 1
- 229960004854 viral vaccine Drugs 0.000 description 1
- 229940051021 yellow-fever virus Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/04—Preserving or maintaining viable microorganisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18451—Methods of production or purification of viral material
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/87—Mycoplasma
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/948—Microorganisms using viruses or cell lines
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9909999.6A GB9909999D0 (en) | 1999-05-04 | 1999-05-04 | Protection of sensitive viruses and bacteria in vaccines |
| GBGB9926698.3A GB9926698D0 (en) | 1999-11-12 | 1999-11-12 | Method for the preserving of viruses, bacteria and biomolecules |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA11936A true OA11936A (en) | 2006-04-12 |
Family
ID=26315490
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| OA1200100290A OA11936A (en) | 1999-05-04 | 2000-05-03 | Method for the preservation of viruses and mycoplasma. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US6664099B1 (ko) |
| EP (1) | EP1175486B1 (ko) |
| JP (1) | JP2002542815A (ko) |
| KR (1) | KR100616195B1 (ko) |
| CN (1) | CN1433465A (ko) |
| AP (1) | AP1521A (ko) |
| AT (1) | ATE366797T1 (ko) |
| AU (1) | AU776982B2 (ko) |
| BR (1) | BR0010249A (ko) |
| CA (1) | CA2365277A1 (ko) |
| DE (1) | DE60035497T2 (ko) |
| DK (1) | DK1175486T3 (ko) |
| EA (1) | EA004131B1 (ko) |
| ES (1) | ES2290028T3 (ko) |
| MX (1) | MXPA01011145A (ko) |
| OA (1) | OA11936A (ko) |
| TR (1) | TR200103149T2 (ko) |
| WO (1) | WO2000066710A2 (ko) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0301436D0 (sv) * | 2003-05-16 | 2003-05-16 | Joakim Westberg | New proteins |
| JP4896006B2 (ja) | 2004-04-08 | 2012-03-14 | バイオマトリカ， インコーポレイテッド | ライフサイエンスのためのサンプル保存とサンプル管理との統合 |
| US8968721B2 (en) | 2005-12-28 | 2015-03-03 | Advanced Bionutrition Corporation | Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same |
| ES2470340T3 (es) | 2005-12-28 | 2014-06-23 | Advanced Bionutrition Corporation | Vehículo de administración para bacterias probi�ticas que comprende una matriz seca de polisac�ridos, sac�ridos y polioles en forma vítrea |
| CA2673120C (en) * | 2006-12-18 | 2012-08-07 | Advanced Bionutrition Corporation | A dry food product containing live probiotic |
| SG10201508397VA (en) | 2007-04-06 | 2015-11-27 | Takeda Vaccines Inc | Methods and compositions for live attenuated viruses |
| WO2009012601A1 (en) | 2007-07-26 | 2009-01-29 | Sanofi Pasteur Limited | Antigen-adjuvant compositions and methods |
| DE102007036695A1 (de) * | 2007-08-03 | 2009-02-05 | Ab Skf | Getriebelageranordnung mit wenigstens einem zweireihigen Schrägkugellager |
| ES2908047T3 (es) | 2009-03-27 | 2022-04-27 | Intervet Int Bv | Vacunas en micropartículas para la vacunación oral o nasal y el refuerzo de animales incluidos los peces |
| NZ597053A (en) | 2009-05-26 | 2014-02-28 | Advanced Bionutrition Corp | Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making |
| EP2529004B1 (en) | 2010-01-28 | 2017-06-07 | Advanced Bionutrition Corporation | Dry glassy composition comprising a bioactive material |
| US9504750B2 (en) | 2010-01-28 | 2016-11-29 | Advanced Bionutrition Corporation | Stabilizing composition for biological materials |
| US9845489B2 (en) | 2010-07-26 | 2017-12-19 | Biomatrica, Inc. | Compositions for stabilizing DNA, RNA and proteins in saliva and other biological samples during shipping and storage at ambient temperatures |
| US9376709B2 (en) | 2010-07-26 | 2016-06-28 | Biomatrica, Inc. | Compositions for stabilizing DNA and RNA in blood and other biological samples during shipping and storage at ambient temperatures |
| CN103140145B (zh) | 2010-08-13 | 2014-08-20 | 高级生物营养公司 | 用于生物材料的干的贮存稳定用组合物 |
| CN114262690A (zh) | 2011-04-15 | 2022-04-01 | 吉恩勒克斯公司 | 减毒的痘苗病毒的克隆毒株及其使用方法 |
| WO2014055960A1 (en) | 2012-10-05 | 2014-04-10 | Genelux Corporation | Energy absorbing-based diagnostic and therapeutic methods employing nucleic acid molecules encoding chromophore-producing enzymes |
| US9725703B2 (en) | 2012-12-20 | 2017-08-08 | Biomatrica, Inc. | Formulations and methods for stabilizing PCR reagents |
| US10238700B2 (en) | 2014-01-02 | 2019-03-26 | Genelux Corporation | Oncolytic virus adjunct therapy with agents that increase virus infectivity |
| CN106572650B (zh) | 2014-06-10 | 2021-08-31 | 生物马特里卡公司 | 在环境温度下稳定凝血细胞 |
| CA2994112C (en) | 2015-07-29 | 2023-08-08 | Advanced Bionutrition Corp. | Stable dry probiotic compositions for special dietary uses |
| EP4242628A3 (en) | 2015-12-08 | 2023-11-08 | Biomatrica, INC. | Reduction of erythrocyte sedimentation rate |
| CN105462840A (zh) * | 2015-12-10 | 2016-04-06 | 浙江卫信生物药业有限公司 | 一种口腔支原体的活体冻干体的制备方法 |
| US20240033347A1 (en) | 2022-07-08 | 2024-02-01 | Viromissile, Inc. | Oncolytic vaccinia viruses and recombinant viruses and methods of use thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8801338D0 (en) * | 1988-01-21 | 1988-02-17 | Quadrant Bioresources Ltd | Preservation of viruses |
| GB9125695D0 (en) * | 1991-12-03 | 1992-01-29 | Mastavac Limited | Medical preparations |
| MX9709716A (es) * | 1995-06-07 | 1998-03-31 | Quadrant Holdings Cambridge | Metodos para incorporar substancias estables dentro de matrices de vidrio celular secas y composiciones obtenidas mediante los mismos. |
| US5766520A (en) * | 1996-07-15 | 1998-06-16 | Universal Preservation Technologies, Inc. | Preservation by foam formation |
-
2000
- 2000-05-03 EA EA200101167A patent/EA004131B1/ru not_active IP Right Cessation
- 2000-05-03 AT AT00927438T patent/ATE366797T1/de not_active IP Right Cessation
- 2000-05-03 CA CA002365277A patent/CA2365277A1/en not_active Abandoned
- 2000-05-03 KR KR1020017014025A patent/KR100616195B1/ko not_active IP Right Cessation
- 2000-05-03 BR BR0010249-0A patent/BR0010249A/pt not_active Application Discontinuation
- 2000-05-03 US US09/980,698 patent/US6664099B1/en not_active Expired - Fee Related
- 2000-05-03 AU AU45844/00A patent/AU776982B2/en not_active Ceased
- 2000-05-03 DE DE60035497T patent/DE60035497T2/de not_active Expired - Fee Related
- 2000-05-03 OA OA1200100290A patent/OA11936A/en unknown
- 2000-05-03 EP EP00927438A patent/EP1175486B1/en not_active Expired - Lifetime
- 2000-05-03 ES ES00927438T patent/ES2290028T3/es not_active Expired - Lifetime
- 2000-05-03 DK DK00927438T patent/DK1175486T3/da active
- 2000-05-03 WO PCT/GB2000/001524 patent/WO2000066710A2/en active IP Right Grant
- 2000-05-03 AP APAP/P/2001/002335A patent/AP1521A/en active
- 2000-05-03 JP JP2000615735A patent/JP2002542815A/ja active Pending
- 2000-05-03 TR TR2001/03149T patent/TR200103149T2/xx unknown
- 2000-05-03 MX MXPA01011145A patent/MXPA01011145A/es active IP Right Grant
- 2000-05-03 CN CN00807149A patent/CN1433465A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AP1521A (en) | 2005-12-22 |
| DE60035497D1 (de) | 2007-08-23 |
| MXPA01011145A (es) | 2003-07-14 |
| AU4584400A (en) | 2000-11-17 |
| DK1175486T3 (da) | 2007-10-29 |
| CN1433465A (zh) | 2003-07-30 |
| WO2000066710A2 (en) | 2000-11-09 |
| US6664099B1 (en) | 2003-12-16 |
| KR20020012201A (ko) | 2002-02-15 |
| EA200101167A1 (ru) | 2002-06-27 |
| BR0010249A (pt) | 2002-02-13 |
| AP2001002335A0 (en) | 2001-12-31 |
| WO2000066710A3 (en) | 2001-02-08 |
| CA2365277A1 (en) | 2000-11-09 |
| ES2290028T3 (es) | 2008-02-16 |
| TR200103149T2 (tr) | 2002-01-21 |
| EP1175486B1 (en) | 2007-07-11 |
| DE60035497T2 (de) | 2007-10-31 |
| AU776982B2 (en) | 2004-09-30 |
| JP2002542815A (ja) | 2002-12-17 |
| EP1175486A2 (en) | 2002-01-30 |
| ATE366797T1 (de) | 2007-08-15 |
| EA004131B1 (ru) | 2003-12-25 |
| KR100616195B1 (ko) | 2006-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| OA11936A (en) | Method for the preservation of viruses and mycoplasma. | |
| EP1187907B1 (en) | Method for the preservation of biologically-active material | |
| Worrall et al. | Xerovac: an ultra rapid method for the dehydration and preservation of live attenuated Rinderpest and Peste des Petits ruminants vaccines | |
| AU2003278166B2 (en) | Immunogenic composition | |
| WO2000023104A1 (fr) | Vaccin lyophilise a virus vivant modifie d'hepatite a et son stabilisant | |
| US8795686B2 (en) | Stable, dried rotavirus vaccine, compositions and process for preparation thereof | |
| US3674864A (en) | Process for stabilizing preparations of interfering viruses | |
| Siegert et al. | The pyrogens of myxoviruses II. Resistance of influenza a pyrogens to heat, ultraviolet, and chemical treatment | |
| CN105797164B (zh) | 一种用于tgev、pedv二联冻干活疫苗的耐热保护剂、其制备方法及应用 | |
| US5024836A (en) | Stable lyophilized live herpes virus vaccine | |
| CN101474410A (zh) | 一种动物用活疫苗耐热冻干保护剂及其制备方法 | |
| Tannock et al. | Freeze-drying of respiratory syncytial viruses for transportation and storage | |
| US3186908A (en) | Calcium lactobionate stabilization of labile antigenic virus vaccine materials | |
| AU622110B2 (en) | A stable lyophilized live herpes virus vaccine | |
| CN114931648A (zh) | 一种猪流行性腹泻和猪传染性胃肠炎二联活疫苗耐热保护剂及其制备方法和应用 | |
| Berge et al. | Preservation of enteroviruses by freeze-drying | |
| CN103893776B (zh) | 羊传染性脓疱病毒细胞弱毒疫苗耐热冻干保护剂及其制备方法和应用 | |
| WO2011154119A1 (en) | Preparation of a stabilized dry oral vaccine composed of a live attenuated virus | |
| Yaqub et al. | Comparative efficacy of stabilizers on the thermostability of Peste des petits Ruminants vaccine | |
| CN103301453A (zh) | 一种猪繁殖与呼吸综合征冻干疫苗及其制备方法 | |
| NO773378L (no) | Baerer for fremstilling av lagringsstabil poliovaksine | |
| RU2127604C1 (ru) | Вакцина против инфекционной бурсальной болезни птиц | |
| RU2182494C1 (ru) | Штамм вируса парагриппа-3 крупного рогатого скота для изготовления диагностических и вакцинных препаратов | |
| CN115678859A (zh) | 一种病毒类疫苗半成品冻存保护剂、制备方法及其应用 |